Lupin unveils Bromfenac Ophthalmic Solution, 0.075% in US Ruchika Sharma14 Feb 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Bromfenac Ophthalmic Solution, 0.075%, after having received an approval...
Submit Animal Toxicity Study Report: CDSCO Panel Tells Lupin on Parkinsonism FDC drug Dr. Divya Colin9 Feb 2024 6:00 PM ISTNew Delhi: Noting that the proposed dose is higher than the approved dose, the Subject Expert Committee (SEC) functional under the Central Drug...
Lupin posts bigger-than-expected rise in Q3 profit Ruchika Sharma8 Feb 2024 2:30 PM ISTMumbai: Indian generic drugmaker Lupin reported a bigger-than-expected rise in its third-quarter profit on Wednesday, helped by strong demand in...
Lupin bags USFDA nod for Bromfenac Ophthalmic Solution, 0.075% Ruchika Sharma7 Feb 2024 11:45 AM ISTBromfenac Ophthalmic Solution, 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients...
Lupin unveils Cyanocobalamin Nasal Spray in US Ruchika Sharma4 Feb 2024 4:30 PM ISTIt is indicated for prevention of vitamin B12 deficiency in adult patients with vitamin B12 requirements more than normal.
Lupin bags USFDA okay Dronedarone Tablets Ruchika Sharma2 Feb 2024 12:06 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration...
Lupin Digital Health, American College of Cardiology introduce Digital Therapeutics Certificate for Cardiologists in India Ruchika Sharma31 Jan 2024 2:30 PM ISTMumbai: Lupin Digital Health, an evidence-based cardiology Digital Therapeutics (DTx) platform and the American College of Cardiology (ACC) have...
Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin29 Jan 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Lupin for the fixed-dose combination (FDC) cardiovascular drug Sacubitril plus...
Lupin bags tentative USFDA approval for Rivaroxaban Tablets Ruchika Sharma24 Jan 2024 11:19 AM ISTThis product will be manufactured at Lupin's Pithampur facility in India.
Lupin Gets CDSCO Panel Nod to Study FDC of Fluticasone, Glycopyrronium, Vilanterol Inhalation Powder Dr. Divya Colin23 Jan 2024 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin bags USFDA nod for hyperuricemia treatment drug Febuxostat Ruchika Sharma19 Jan 2024 1:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
Lupin bags USFDA nod for hypertension drug Propranolol Hydrochloride ER Ruchika Sharma15 Jan 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
